Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

PYRIDOSTIGMINE BROMIDE

PYRIDOSTIGMINE BROMIDE

Standard Dose
105MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview PYRIDOSTIGMINE BROMIDE is listed in Drugs@FDA under application 217604 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient PYRIDOSTIGMINE BROMIDE Form and strength TABLET, EXTENDED RELEASE;ORAL - 105MG Sponsor AMNEAL Submission history Latest submission status date: 2024-10-04 00:00:00.

Structured Monograph

Clinical summary

Approval overview PYRIDOSTIGMINE BROMIDE is listed in Drugs@FDA under application 217604 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient PYRIDOSTIGMINE BROMIDE Form and strength TABLET, EXTENDED RELEASE;ORAL - 105MG Sponsor AMNEAL Submission history Latest submission status date: 2024-10-04 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.